While countries around the world are expanding legal cannabis access and innovation, the U.S. is moving toward a ban that could eliminate the hemp products Americans have come to rely on. Global roundup: Over 3,000 US stores now sell hemp-derived THC beverages (2-10mg per can). The Czech Republic legalized home cannabis growing effective Jan 1, 2026.
Hemp Beverage CEO: Even Legal Gummies Would Be Illegal to MAKE Under Container Rules
Even if the CBD gummy in your hand is legal, the liquid used to manufacture it may not be—meaning American CBD production could be forced offshore or shut down entirely. Adam Terry, CEO of hemp beverage company Cantrip, explains a critical flaw: even if individually wrapped gummies could contain 0.4mg THC, the liquid used to make the molds would exceed the container limit on intermediates—making them illegal to manufacture in the US. The intermediate product rule means CBD crude and distillate routinely exceed 0.3% total THC during processing, even when the final product is non-intoxicating.
Oregon Proposes 17% Tax on Hemp-Derived Cannabinoid Products in 2026 Session
Oregon wants to tax hemp CBD and cannabinoid products at the same 17% rate as marijuana, which could significantly raise prices on the wellness products you buy. Oregon’s 2026 short session (35 days) includes HB 4139, which would impose a 17% retail sales tax on industrial hemp-derived cannabinoid products—matching the marijuana tax rate. The bill also defines ‘container’ and ‘industrial hemp-derived cannabinoid product,’ requires individually packaged edibles capped at 10mg per piece, and mandates criminal background checks for hemp handlers.
Hemp Beverage Companies Face Existential Threat Under 0.4mg THC Container Limit
The new federal THC limit of 0.4mg per container would make the low-dose THC seltzers and beverages many people enjoy as alcohol alternatives completely illegal. The Nov 2026 rule caps final products at 0.4mg total THC per container. A typical ‘low-strength’ THC seltzer contains 2-10mg per can—5-25x over the limit.
Wageningen Scientists ‘Resurrect’ Ancient Cannabis Enzymes with Medical Promise
Scientists have unlocked ancient cannabis enzymes that could make it far easier to produce CBC, a promising anti-inflammatory cannabinoid that today’s plants can’t make in large quantities. Researchers at Wageningen University reconstructed extinct cannabinoid-producing enzymes that were active millions of years ago. These ancestral enzymes are ‘generalists’—capable of producing THC, CBD, and CBC simultaneously, unlike modern specialized enzymes.
Top Issues in the Cannabis Industry for 2026: Banking, Hemp Redefinition, and Market Contraction
Popular hemp products like delta-8, THCA flower, and HHC will be reclassified as Schedule I controlled substances, meaning the products you currently buy legally could become federally illegal overnight. Legal analysis lays out how the new hemp law converts the 2018 Farm Bill ‘patchwork loophole’ into a clear federal prohibition framework. Delta-8, delta-10, THCA flower, HHC, and THCP will all fall outside ‘hemp’ and be treated as Schedule I.
2026 Farm Bill Draft Would Reduce Regulatory Burdens for Industrial Hemp Producers
The new Farm Bill protects industrial hemp farmers but offers zero protection for the cannabinoid products—like CBD oils and gummies—that millions of consumers use every day. House Agriculture Committee Chairman Glenn Thompson filed the 802-page Farm, Food, and National Security Act of 2026 (H.R. 7567).
FDA Misses Congressionally Mandated Deadline to Publish Cannabinoid Lists
If the FDA can’t even define which cannabinoids are legal, the hemp CBD products you rely on could disappear without warning when the November 2026 ban takes effect. The FDA has missed its Feb 10 deadline to publish lists of naturally occurring cannabinoids, THC-class compounds, and those with ‘similar effects.’ The lists were mandated by Congress under the Nov 2025 spending bill. HHS told reporters it intended to meet the deadline, but nothing has materialized.
Normal Pressure Hydrocephalus: 7 Surprising Facts You Should Know
Billy Joel’s diagnosis of normal pressure hydrocephalus (NPH) is a plot twist with hope baked in—because unlike most brain disorders, this one can actually be reversed. In this blog, we explore what NPH really is, how a shunt can save cognition, and why cannabis might offer a side-serving of relief for some. If you’ve ever blamed aging for mental slips or clumsy steps, it’s time to ask better questions—and maybe even thank Billy for the wake-up call.
Jordan Tischler Retirement: What Boston Patients Should Know
Dr. Jordan Tischler, a well-known cannabis physician in Boston, has officially retired from clinical practice, leaving many patients searching for their next steps. This page offers clear, respectful guidance for those seeking cannabis care in Massachusetts after his departure. Whether you need certification renewal, telemedicine options, or trusted physician referrals, you’re in the right place.